Medical Condition News

RSS

Laser-based infrared molecular fingerprinting detects common cancers

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies.

9 Apr 2025

Dynamic BH3 profiling offers personalized lung cancer therapies

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

9 Apr 2025

Cell-by-cell analysis reveals brain changes in Tourette syndrome

In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have pinpointed exactly which cells are perturbed and how they malfunction, revealing how different types of brain cells are affected by the condition.

9 Apr 2025

Neural organoids offer insight into mechanisms of dementia

Researchers at The Ohio State University Wexner Medical Center and College of Medicine have discovered a new way that neurons act in neurodegeneration by using human neural organoids – also known as "mini-brain" models – from patients with frontotemporal lobar degeneration (FTLD).

9 Apr 2025

Chemotherapy linked to changes in brain connectivity in breast cancer patients

New research published in the Journal of Magnetic Resonance Imaging has uncovered changes in brain connectivity during chemotherapy in patients with breast cancer.

9 Apr 2025

Tooth and gum problems common among teenage footballers in England

The prevalence of tooth and gum issues among teenage (academy) professional footballers in England is high, finds research published in the open access journal BMJ Open Sport & Exercise Medicine.

9 Apr 2025

New hospital program helps opioid patients stay in treatment after discharge

Offering hospitalized patients who are struggling with opioid use disorder a medication to treat their addiction makes it more likely that they will continue with follow-up care after they are discharged, a new study finds.

9 Apr 2025

This bill aims to help firefighters with cancer. Getting it passed is just the beginning.

As firefighters battled the catastrophic blazes in Los Angeles County in January, California's U.S. senators, Adam Schiff and Alex Padilla, signed onto legislation with a simple aim: Provide federal assistance to first responders diagnosed with service-related cancer.

9 Apr 2025

What happens if you significantly increase dietary folic acid intake?

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, highlighting the need for optimal levels.

9 Apr 2025

Early-life ozone exposure linked to increased risk of childhood asthma and wheezing

Researchers investigate the impact of early-life ozone exposure on asthma and wheezing in children alone and in combination with other air pollutants.

9 Apr 2025

Study links food additive mixtures to increased risk of type 2 diabetes

Food additive mixtures are an everyday feature of our diets, especially through ultra-processed foods.

9 Apr 2025

Relaxation methods offer temporary relief for high blood pressure

Relaxation techniques may help lower high blood pressure-at least in the short term-but the longer term effects are unclear, finds a pooled data analysis of the existing research published in the open access journal BMJ Medicine.

9 Apr 2025

Tiny facial movements could help better understand social communication in autistic individuals

A study led by Rutgers University-New Brunswick researchers suggests that tiny facial movements – too slight for the human eye to notice – could help scientists better understand social communication in people with autism.

9 Apr 2025

Study finds connection between hearing impairment and heart failure risk

Hearing loss is linked to a heightened risk of developing heart failure, with the psychological distress caused by the impairment taking a key role in the observed association, finds a large long term study, published online in the journal Heart.

9 Apr 2025

New award to recognize contributions linking neuroscience to psychiatric diagnosis and treatment

Mental health is in crisis worldwide. While the neurosciences are advancing rapidly, psychiatry still struggles to diagnose and effectively treat many disorders. The Synapsy Center for Neuroscience and Mental Health Research at the University of Geneva, Switzerland, is launching a new international prize to reward those who bring these two worlds closer together.

9 Apr 2025

Breakthrough nanoparticle delivery method targets brain inflammation for multiple conditions

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease, multiple sclerosis, Parkinson's disease and cancer cachexia.

9 Apr 2025

IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.

8 Apr 2025

Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for pulmonary hypertension (PH), a condition that places patients at risk for right heart failure and death.

8 Apr 2025

New molecular target identified for pancreatic cancer treatment

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have identified a new molecular target for treating pancreatic cancer, reports a Gastroenterology study published today.

8 Apr 2025

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing secondary progressive multiple sclerosis (SPMS).

8 Apr 2025

Previous
1
...
16
17
18
19
20
21
22
...
5612
Next

Medical Condition News

Laser-based infrared molecular fingerprinting detects common cancers

Dynamic BH3 profiling offers personalized lung cancer therapies

Cell-by-cell analysis reveals brain changes in Tourette syndrome

Neural organoids offer insight into mechanisms of dementia

Chemotherapy linked to changes in brain connectivity in breast cancer patients

Tooth and gum problems common among teenage footballers in England

New hospital program helps opioid patients stay in treatment after discharge

This bill aims to help firefighters with cancer. Getting it passed is just the beginning.

What happens if you significantly increase dietary folic acid intake?

Early-life ozone exposure linked to increased risk of childhood asthma and wheezing

Study links food additive mixtures to increased risk of type 2 diabetes

Relaxation methods offer temporary relief for high blood pressure

Tiny facial movements could help better understand social communication in autistic individuals

Study finds connection between hearing impairment and heart failure risk

New award to recognize contributions linking neuroscience to psychiatric diagnosis and treatment

Breakthrough nanoparticle delivery method targets brain inflammation for multiple conditions

IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers

Study highlights pulmonary artery denervation as a key intervention for pulmonary hypertension

New molecular target identified for pancreatic cancer treatment

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News